Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with S

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
7188 Q3 2021 SCOTCHPAK 1022 TRANSDERMAL SYSTEM 364.46 mg Correction
7188 Q4 2021 SCOTCHPAK 9755 TRANSDERMAL SYSTEM 364.46 mg Correction
7445 Q3 2021 SODIUM BENZOATE ORAL TABLET, COATED 9.00 mg Correction
7445 Q4 2021 SODIUM BENZOATE ORAL TABLET, COATED 0.20 mg Correction
7827 Q3 2021 SODIUM HYDROXIDE ORAL CAPSULE, EXTENDED RELEASE 0.03 mg Correction
7827 Q4 2021 SODIUM HYDROXIDE ORAL CAPSULE, EXTENDED RELEASE 0.01 mg Correction
8063 Q3 2021 SODIUM PHOSPHATE, DIBASIC ORAL SUSPENSION 8.00 mg/ 1.00 ml Correction
8063 Q4 2021 SODIUM PHOSPHATE, DIBASIC ORAL SUSPENSION 4.50 mg/ 1.00 ml Correction
8084 Q3 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS INTRATHECAL INJECTION, SOLUTION 0.01 %w/w Correction
8084 Q4 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS INTRATHECAL INJECTION, SOLUTION 0.01 %w/v Correction
8376 Q3 2021 SODIUM SULFATE OPHTHALMIC SUSPENSION 1.20 %w/w Correction
8376 Q4 2021 SODIUM SULFATE OPHTHALMIC SUSPENSION 1.20 %w/v Correction
8528 Q3 2021 SORBITOL NASAL SPRAY 44.80 mg/ 1.00 ml Correction
8528 Q4 2021 SORBITOL NASAL SPRAY 6.17 mg/ 1.00 ml Correction
8541 Q3 2021 SORBITOL ORAL SOLUTION 18000 mg Correction
8541 Q4 2021 SORBITOL ORAL SOLUTION 12000 mg Correction
8643 Q3 2021 STARCH VAGINAL TABLET 305.00 mg Correction
8643 Q4 2021 STARCH VAGINAL TABLET 260.00 mg Correction
7128 Q3 2021 SACCHARIN ORAL SYRUP 3.50 mg/ 5.00 ml MDE Replacement
7128 Q4 2021 SACCHARIN ORAL SYRUP 8 mg MDE Replacement
7138 Q3 2021 SACCHARIN SODIUM BUCCAL FILM 2.99 mg MDE Replacement
7138 Q4 2021 SACCHARIN SODIUM BUCCAL FILM 2.99 mg MDE Replacement
7139 Q3 2021 SACCHARIN SODIUM BUCCAL FILM, SOLUBLE 0.57 mg MDE Replacement
7139 Q4 2021 SACCHARIN SODIUM BUCCAL FILM, SOLUBLE 2 mg MDE Replacement
7206 Q3 2021 SESAME OIL ORAL CAPSULE 162.50 mg MDE Replacement
7206 Q4 2021 SESAME OIL ORAL CAPSULE 2325 mg MDE Replacement
7269 Q3 2021 SILICON DIOXIDE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 1.60 mg MDE Replacement
7269 Q4 2021 SILICON DIOXIDE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 2.4 mg MDE Replacement
7368 Q3 2021 SODIUM ACETATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 125.00 mg MDE Replacement
7368 Q4 2021 SODIUM ACETATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 125 mg MDE Replacement
7383 Q3 2021 SODIUM ACETATE SUBCUTANEOUS INJECTION 0.98%w/v MDE Replacement
7383 Q4 2021 SODIUM ACETATE SUBCUTANEOUS INJECTION 9.8 mg MDE Replacement
7420 Q3 2021 SODIUM BENZOATE BUCCAL FILM 0.96 mg MDE Replacement
7420 Q4 2021 SODIUM BENZOATE BUCCAL FILM 0.96 mg MDE Replacement
7421 Q3 2021 SODIUM BENZOATE BUCCAL FILM, SOLUBLE 0.69 mg MDE Replacement
7421 Q4 2021 SODIUM BENZOATE BUCCAL FILM, SOLUBLE 3 mg MDE Replacement
7555 Q3 2021 SODIUM CARBONATE ORAL GRANULE, FOR SUSPENSION 6.50 mg MDE Replacement
7555 Q4 2021 SODIUM CARBONATE ORAL GRANULE, FOR SUSPENSION 6.5 mg MDE Replacement
7561 Q3 2021 SODIUM CARBONATE ORAL TABLET, EXTENDED RELEASE 30.00 mg MDE Replacement
7561 Q4 2021 SODIUM CARBONATE ORAL TABLET, EXTENDED RELEASE 80 mg MDE Replacement
7584 Q3 2021 SODIUM CHLORIDE EPIDURAL INJECTION 24.00 %w/v MDE Replacement
7584 Q4 2021 SODIUM CHLORIDE EPIDURAL INJECTION 583.62 mg MDE Replacement
7585 Q3 2021 SODIUM CHLORIDE EPIDURAL INJECTION, SOLUTION 0.90 %w/v MDE Replacement
7585 Q4 2021 SODIUM CHLORIDE EPIDURAL INJECTION, SOLUTION 216.65 mg MDE Replacement
7597 Q3 2021 SODIUM CHLORIDE INTRACARDIAC INJECTION 0.70 %w/v MDE Replacement
7597 Q4 2021 SODIUM CHLORIDE INTRACARDIAC INJECTION 63 mg MDE Replacement
7623 Q3 2021 SODIUM CHLORIDE INTRATHECAL INJECTION, SOLUTION 0.90 %w/v MDE Replacement
7623 Q4 2021 SODIUM CHLORIDE INTRATHECAL INJECTION, SOLUTION 122.4 mg MDE Replacement
7656 Q3 2021 SODIUM CHLORIDE ORAL CAPSULE, EXTENDED RELEASE 20.72 mg MDE Replacement
7656 Q4 2021 SODIUM CHLORIDE ORAL CAPSULE, EXTENDED RELEASE 41.44 mg MDE Replacement
7672 Q3 2021 SODIUM CHLORIDE PARENTERAL INJECTION 24.00 %w/v MDE Replacement
7672 Q4 2021 SODIUM CHLORIDE PARENTERAL INJECTION 583.62 mg MDE Replacement
7845 Q3 2021 SODIUM HYDROXIDE ORAL TABLET, ORALLY DISINTEGRATING 0.16 mg MDE Replacement
7845 Q4 2021 SODIUM HYDROXIDE ORAL TABLET, ORALLY DISINTEGRATING 0.62 mg MDE Replacement
7942 Q3 2021 SODIUM LAURYL SULFATE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 0.30 mg MDE Replacement
7942 Q4 2021 SODIUM LAURYL SULFATE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 0.6 mg MDE Replacement
7964 Q3 2021 SODIUM LAURYL SULFATE VAGINAL CREAM 0.33 %w/w MDE Replacement
7964 Q4 2021 SODIUM LAURYL SULFATE VAGINAL CREAM 12 mg MDE Replacement
8016 Q3 2021 SODIUM OLEATE INTRAVENOUS INJECTION, EMULSION 0.48 %w/v MDE Replacement
8016 Q4 2021 SODIUM OLEATE INTRAVENOUS INJECTION, EMULSION 90 mg MDE Replacement
8075 Q3 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS INTRA-ARTICULAR INJECTION 0.71 %w/v MDE Replacement
8075 Q4 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS INTRA-ARTICULAR INJECTION 28.4 mg MDE Replacement
8077 Q3 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS INTRALESIONAL INJECTION 0.71 %w/v MDE Replacement
8077 Q4 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS INTRALESIONAL INJECTION 28.4 mg MDE Replacement
8095 Q3 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS NASAL SPRAY, METERED 6.48 mg/ 1.00 ml MDE Replacement
8095 Q4 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS NASAL SPRAY, METERED 7.1 mg MDE Replacement
8107 Q3 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS ORAL TABLET, EXTENDED RELEASE 110.00 mg MDE Replacement
8107 Q4 2021 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS ORAL TABLET, EXTENDED RELEASE 210 mg MDE Replacement
8183 Q3 2021 SODIUM PHOSPHATE, MONOBASIC BUCCAL FILM, SOLUBLE 0.76 mg MDE Replacement
8183 Q4 2021 SODIUM PHOSPHATE, MONOBASIC BUCCAL FILM, SOLUBLE 3 mg MDE Replacement
8260 Q3 2021 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE INTRA-ARTICULAR INJECTION 0.34 %w/v MDE Replacement
8260 Q4 2021 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE INTRA-ARTICULAR INJECTION 13.6 mg MDE Replacement
8261 Q3 2021 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE INTRALESIONAL INJECTION 0.68 %w/v MDE Replacement
8261 Q4 2021 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE INTRALESIONAL INJECTION 13.6 mg MDE Replacement
8291 Q3 2021 SODIUM PHOSPHATE, TRIBASIC BUCCAL FILM, SOLUBLE 0.76 mg MDE Replacement
8291 Q4 2021 SODIUM PHOSPHATE, TRIBASIC BUCCAL FILM, SOLUBLE 3.04 mg MDE Replacement
8315 Q3 2021 SODIUM POLYSTYRENE SULFONATE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 83.18 mg MDE Replacement
8315 Q4 2021 SODIUM POLYSTYRENE SULFONATE ORAL TABLET, CHEWABLE, EXTENDED RELEASE 124.78 mg MDE Replacement
8447 Q3 2021 SORBIC ACID ORAL TABLET, FILM COATED 0.94 mg MDE Replacement
8447 Q4 2021 SORBIC ACID ORAL TABLET, FILM COATED 5 mg MDE Replacement
8448 Q3 2021 SORBIC ACID ORAL TABLET, FILM COATED, EXTENDED RELEASE 0.40 mg MDE Replacement
8448 Q4 2021 SORBIC ACID ORAL TABLET, FILM COATED, EXTENDED RELEASE 0.8 mg MDE Replacement
8474 Q3 2021 SORBITAN MONOOLEATE ORAL TABLET 1.70 mg MDE Replacement
8474 Q4 2021 SORBITAN MONOOLEATE ORAL TABLET 6.27 mg MDE Replacement
8478 Q3 2021 SORBITAN MONOOLEATE ORAL TABLET, FILM COATED 1.70 mg MDE Replacement
8478 Q4 2021 SORBITAN MONOOLEATE ORAL TABLET, FILM COATED 12 mg MDE Replacement
8479 Q3 2021 SORBITAN MONOOLEATE ORAL TABLET, FILM COATED, EXTENDED RELEASE 1.00 mg MDE Replacement
8479 Q4 2021 SORBITAN MONOOLEATE ORAL TABLET, FILM COATED, EXTENDED RELEASE 2 mg MDE Replacement
8629 Q3 2021 STARCH ORAL TABLET 1000.00 mg MDE Replacement
8629 Q4 2021 STARCH ORAL TABLET 2440 mg MDE Replacement
8681 Q3 2021 STARCH, POTATO ORAL TABLET 80.59 mg MDE Replacement
8681 Q4 2021 STARCH, POTATO ORAL TABLET 458.4 mg MDE Replacement
8743 Q3 2021 STEARIC ACID ORAL TABLET, EXTENDED RELEASE 187.50 mg MDE Replacement
8743 Q4 2021 STEARIC ACID ORAL TABLET, EXTENDED RELEASE 200 mg MDE Replacement
8744 Q3 2021 STEARIC ACID ORAL TABLET, FILM COATED 22.00 mg MDE Replacement
8744 Q4 2021 STEARIC ACID ORAL TABLET, FILM COATED 176 mg MDE Replacement
8781 Q3 2021 STEARYL ALCOHOL VAGINAL CREAM 8.50 %w/w MDE Replacement
8781 Q4 2021 STEARYL ALCOHOL VAGINAL CREAM 280 mg MDE Replacement
8790 Q3 2021 STYRENE/ISOPRENE/STYRENE BLOCK COPOLYMER TOPICAL SYSTEM 519.75 mg MDE Replacement
8790 Q4 2021 STYRENE/ISOPRENE/STYRENE BLOCK COPOLYMER TOPICAL SYSTEM 519.75 mg MDE Replacement
8796 Q3 2021 SUCCINIC ACID ORAL POWDER, FOR SUSPENSION 1.00 mg MDE Replacement
8796 Q4 2021 SUCCINIC ACID ORAL POWDER, FOR SUSPENSION 5.01 mg MDE Replacement
8810 Q3 2021 SUCRALOSE ORAL POWDER, FOR SOLUTION 41.40 mg MDE Replacement
8810 Q4 2021 SUCRALOSE ORAL POWDER, FOR SOLUTION 82.6 mg MDE Replacement
8812 Q3 2021 SUCRALOSE ORAL SOLUTION 230.00 mg MDE Replacement
8812 Q4 2021 SUCRALOSE ORAL SOLUTION 800 mg MDE Replacement
8829 Q3 2021 SUCROSE INTRAVENOUS INJECTION, EMULSION 5.40 %w/v MDE Replacement
8829 Q4 2021 SUCROSE INTRAVENOUS INJECTION, EMULSION 970 mg MDE Replacement
7239 Q4 2021 SILICON DIOXIDE BUCCAL TABLET, DELAYED RELEASE 0.46 mg Deletion
8440 Q4 2021 SORBIC ACID ORAL SOLUTION/ DROPS 2.00 mg/ 1.00 ml Deletion

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English